Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease
Clinical trial NCT01806896 · COMPLETED
Trial details
- NCT number
- NCT01806896
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-01-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.